SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-15-007467
Filing Date
2015-04-16
Accepted
2015-04-16 08:11:36
Documents
5
Effectiveness Date
2015-04-16

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A pdli20150402_defa14a.htm DEFA14A 29404
2 a4.jpg GRAPHIC 24706
3 a3.jpg GRAPHIC 42608
4 a2.jpg GRAPHIC 120869
5 a1.jpg GRAPHIC 76620
  Complete submission text file 0001437749-15-007467.txt   395769
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19756 | Film No.: 15773298
SIC: 2836 Biological Products, (No Diagnostic Substances)